Hikma Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Hikma Pharmaceuticals's balance sheet done over the years? Its assets were worth $4,680,000,000 last year, which is more than in the previous period. 53% of Hikma Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $2,471,000,000, which means an increase by 6% compared compared to last year.
Debt to Assets
| 2014 | 2251000000 | 1.03B | 45.98% |
|---|---|---|---|
| 2015 | 2597000000 | 1.24B | 47.94% |
| 2016 | 4363000000 | 1.95B | 44.74% |
| 2017 | 3388000000 | 1.86B | 54.9% |
| 2018 | 3497000000 | 1.8B | 51.47% |
| 2019 | 3930000000 | 1.80B | 45.83% |
| 2020 | 4135000000 | 1.98B | 48.05% |
| 2021 | 4372000000 | 1.90B | 43.57% |
| 2022 | 4471000000 | 2.32B | 51.96% |
| 2023 | 4680000000 | 2.47B | 52.8% |
HKMPY Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 205M | 270M | 426M | 323M | 442M | 276M | 227M | 155M | 553M | 280M |
Short term investments | 24M | 22M | 24M | 24M | 23M | 21M | 22M | 20M | 46M | 39M |
Net receivables | 789M | 843M | 876M | 796M | 799M | 825M | 650M | 768M | 432M | 384M |
Inventory | 891M | 776M | 695M | 757M | 568M | 528M | 488M | 459M | 251M | 273M |
Other current assets | 191M | 110M | 97M | 46M | 39M | 18M | 187M | 66M | 104M | 76M |
Total current assets | 2.1B | 1.99B | 2.09B | 1.92B | 1.84B | 1.66B | 1.57B | 1.44B | 1.36B | 1.01B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 1.14B | 1.08B | 1.14B | 1.06B | 962M | 870M | 828M | 969M | 507M | 514M |
Goodwill | 388M | 389M | 285M | 289M | 282M | 279M | 282M | 682M | 292M | 314M |
Intangible assets | 712M | 735M | 607M | 587M | 552M | 487M | 503M | 1.03B | 315M | 288M |
Long term investments | 65M | 53M | 33M | 24M | 20M | 17M | 44M | -6M | 7M | 16M |
Other non-current assets | 48M | 22M | 24M | 24M | 23M | 51M | 22M | 61M | 46M | 39M |
Total non-current assets | 2.58B | 2.47B | 2.27B | 2.21B | 2.08B | 1.82B | 1.81B | 2.91B | 1.23B | 1.23B |
Total assets | 4.68B | 4.47B | 4.37B | 4.13B | 3.93B | 3.49B | 3.38B | 4.36B | 2.59B | 2.25B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 193M | 294M | 100M | 105M | 65M | 382M | 432M | 240M | 65M |
Short term debt | 161M | 148M | 121M | 168M | 578M | 75M | 87M | 118M | 116M | 394M |
Total current liabilities | 1.33B | 1.07B | 1.01B | 1.02B | 1.47B | 893M | 797M | 918M | 592M | 841M |
| Non-current liabilities: | ||||||||||
Long term debt | 1.03B | 1.13B | 725M | 764M | 107M | 562M | 690M | 742M | 612M | 168M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 77M | 92M | 140M | 164M | 203M | 329M | 324M | 277M | 20M | 1M |
Total non-current liabilities | 1.13B | 1.24B | 889M | 959M | 330M | 907M | 1.06B | 1.03B | 653M | 194M |
Total liabilities | 2.47B | 2.32B | 1.90B | 1.98B | 1.80B | 1.8B | 1.86B | 1.95B | 1.24B | 1.03B |